Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

172
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
172

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

What should the urologist know on the management of kidney cancer in patients with Von Hippel-Lindau syndrome? Recommendations of the European Association of Urology (EAU) Young Academic Urologists (YAU) Renal Cancer Working Group.

World journal of urology·2026
Same author

Redefining clinical success in minimally invasive surgery for BPH: A composite endpoint integrating ejaculatory function, urinary improvement, and safety metrics.

Urologia·2026
Same author

A preoperative Artificial Intelligence model to estimate cancer-specific mortality in nonmetastatic kidney cancer patients.

Nature communications·2026
Same author

First-in-human <i>ex-vivo</i> validation of carbonic anhydrase IX-PET for high-risk renal cancer (CAT-VHL - PNRR-POC-2023-12377493).

Theranostics·2026
Same author

Sutureless Purely Off-clamp Robotic Partial Nephrectomy: Evidence from a Randomized Controlled Noninferiority Trial.

European urology·2026
Same author

Interpreting Matched Analyses of Partial Versus Radical Nephrectomy for cT2 Tumors: Methodological Caveats and Clinical Implications.

The Journal of urology·2026

Related Experiment Video

Updated: Nov 30, 2025

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

8.6K

Robot-assisted partial nephrectomy: 7-year outcomes.

Umberto Carbonara1,2, Giuseppe Simone3, Umberto Capitanio4,5

  • 1Division of Urology, VCU Health, Richmond, VA, USA.

Minerva Urology and Nephrology
|November 17, 2020
PubMed
Summary
This summary is machine-generated.

Robot-assisted partial nephrectomy (RAPN) shows excellent 7-year oncologic and functional outcomes for malignant renal masses. This procedure offers results comparable to traditional open and laparoscopic surgeries, supporting its long-term efficacy.

More Related Videos

Robot-Assisted Kidney Transplantation
07:30

Robot-Assisted Kidney Transplantation

Published on: July 19, 2021

4.0K
Robot-Assisted Radical Antegrade Modular Pancreatosplenectomy Including Resection and Reconstruction of the Spleno-Mesenteric Junction
12:34

Robot-Assisted Radical Antegrade Modular Pancreatosplenectomy Including Resection and Reconstruction of the Spleno-Mesenteric Junction

Published on: January 3, 2020

17.1K

Related Experiment Videos

Last Updated: Nov 30, 2025

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

8.6K
Robot-Assisted Kidney Transplantation
07:30

Robot-Assisted Kidney Transplantation

Published on: July 19, 2021

4.0K
Robot-Assisted Radical Antegrade Modular Pancreatosplenectomy Including Resection and Reconstruction of the Spleno-Mesenteric Junction
12:34

Robot-Assisted Radical Antegrade Modular Pancreatosplenectomy Including Resection and Reconstruction of the Spleno-Mesenteric Junction

Published on: January 3, 2020

17.1K

Area of Science:

  • Urology
  • Oncology
  • Minimally Invasive Surgery

Background:

  • Robot-assisted partial nephrectomy (RAPN) is increasingly used for renal masses.
  • Long-term outcome data for RAPN remains limited.
  • This study reports on long-term oncologic and functional results of RAPN.

Purpose of the Study:

  • To evaluate the long-term oncologic and functional outcomes of robot-assisted partial nephrectomy (RAPN).
  • To assess the durability of RAPN for malignant renal masses up to 7 years post-procedure.

Main Methods:

  • Retrospective analysis of an international multicenter database.
  • Included patients underwent RAPN for malignant renal masses between 2009-2013 with ≥3-year follow-up.
  • Oncologic outcomes (OS, DFS, CSS) and renal function were analyzed using Kaplan-Meier.

Main Results:

  • Eighty-five patients with a median follow-up of 88 months were analyzed.
  • Excellent 7-year oncologic survival rates: OS 91.7%, CSS 97.7%, DFS 91.7%.
  • Renal functional outcomes showed 20.1% CKD upstaging.

Conclusions:

  • Robot-assisted partial nephrectomy (RAPN) demonstrates excellent long-term oncologic control.
  • Functional outcomes at 7 years are comparable to historical open and laparoscopic series.
  • RAPN is a durable and effective option for managing malignant renal masses.